| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Arrest Trade Barriers by Free Trade Agreements |
|
Digg It - Arrest Trade Barriers by Free Trade Agreements
Arrest trade barriers by free trade agreements following international standards Trade barriers are artificial disincentive to export or import traders. Example of trade barriers are According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tariff, quota and unnecessary import/export license requirements slapped against foreign traders to favor local traders. Traders who suffer from these trade barriers are imposed add ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in itional costs that raises their trade prices, thus, it will be hard for them to compete fairly on pricing issues. Once these foreign traders experience losses because it will loose g lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. od amount of customer due to high cost, moving out from the trade favors local traders and suppliers. Economists believe that trade barriers decrease overall economic efficiency. Th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is practice deprives local consumers of the goods from other nations because the government safeguards local traders. This may be good because there is a fair chance for local players d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to get better, however healthy trading including foreign goods and services might be better. To arrest issues against trade barriers imposed on foreign traders, the United Nations se ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t up standards and procedure promoting free trade. Free trade promotes the recognition of the important contribution of international standards and conformity assessment, which can a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ffect efficiency of production and facilitation of international trade conduct. Removing trade barriers, otherwise known as free trade encourages conformity to international standard nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically that may lead to open trading between nations. Even with the advent of free trade, respect of trader's intellectual property rights may still need to accord due respect. This does n and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ot necessarily favor one against the other. But to respect the rights and privileges of the intellectual proprietor. This is an ethical way of doing business. Foreign traders should n ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t have a problem with this because just the same, they would want other traders to respect their intellectual property rights if ever. Free trade eliminates the possibility of briber ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a y, corruption and imposing undue payoffs. This is because this practice of cashing in on foreign traders may result to a barrier that prevents foreign traders to compete fairly and sq dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod uarely in the marketplace. Should this happen, consumers will suffer because traders will get back at them on issues such as pricing and quality of service. Removal of trade barriers cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin except for reasons of national security and health is the main purpose of free trade agreements such as the North American Free Trade Agreement (NAFTA), European Free Trade Agreement, tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen European Union and South American Community Nation. These agreements ensure foreign traders some leeway on trade barriers; if not at all eradicate it. The United Nations Internation t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel l Standards plays a big role in ensuring protection of traders and industries. For certain industries, however, such as agriculture and steel, even those countries that promote free ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust trade extend heavy subsidy to local players. This is a safeguard of the government for the growth of these industries in their country. This issue on subsidy may still be tolerable t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products han other trade barriers that burden and costs foreign trader, especially corruption. Finally, nations should avoid repeated use of trade barriers against each other to avoid trade w . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rs that will not benefit anybody in the end. Free trade promotes economic efficiency, thus nations should recognize open trading to benefit from globalization. Free trade allows cons elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip umers to enjoy goods from other nations, which commonly they will not be able to have access on should trade barriers continue to prejudice foreign traders hoping to enter the country tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Guide to Mergers and Acquisitions Medical Billing - War Of The Worlds
|